John G. Singer 8/30/22 John G. Singer 8/30/22

Re: 'Market Access' Innovation in the Pharmaceutical Industry

Dylan Winn-Brown 8/25/22 Dylan Winn-Brown 8/25/22

The Four Stages of Ecosystem-Centered Market Strategy

John G. Singer 4/18/22 John G. Singer 4/18/22

Who Wins the Award for Health System Value?

John G. Singer 2/8/22 John G. Singer 2/8/22

Aduhelm and Strategic Collapse at Biogen

John G. Singer 1/19/22 John G. Singer 1/19/22

What is "Value" in Healthcare?

John G. Singer 12/30/21 John G. Singer 12/30/21

Goodbye to All That

John G. Singer 12/22/20 John G. Singer 12/22/20

Strategic Fit for the Next Healthcare

John G. Singer 11/13/20 John G. Singer 11/13/20

Fear and Loathing in the Doldrums

John G. Singer 8/10/20 John G. Singer 8/10/20

Why "Medication Adherence" is a Lunatic Endeavor

John G. Singer 4/1/20 John G. Singer 4/1/20

The Coronavirus Sparks a Feedback Loop

Dylan Winn-Brown 5/1/19 Dylan Winn-Brown 5/1/19

Pharma Flailing

Dylan Winn-Brown 4/25/19 Dylan Winn-Brown 4/25/19

Another "Digital Transformation" Goes Off the Rails

Dylan Winn-Brown 4/12/19 Dylan Winn-Brown 4/12/19

Overload and Boredom as Points of Innovation in Health Care

Dylan Winn-Brown 3/28/19 Dylan Winn-Brown 3/28/19

Healthcare's 'Our Value is to be Valuable' Problem

Dylan Winn-Brown 3/17/19 Dylan Winn-Brown 3/17/19

Government Calling Out the Drug Industry for Being Too Conservative?

Dylan Winn-Brown 3/12/19 Dylan Winn-Brown 3/12/19

Recidivism as an Outcomes Measure

Dylan Winn-Brown 3/7/19 Dylan Winn-Brown 3/7/19

On Innovation Stagnation in Healthcare